首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Biomedicines

Biomedicines杂志,由Multidisciplinary Digital Publishing Institute (MDPI)出版,于2013年创刊,4 issues/year,出版语言English,ISSN:2227-9059,E-ISSN:2227-9059。

投稿咨询
Biomedicines
Biomedicines
Biomedicines
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
4.5
CiteScore
7.8
期刊收录
SCI、SCIE

Biomedicines(中文译名:《生物医药》),ISSN:2227-9059,EISSN:2227-9059,是Multidisciplinary Digital Publishing Institute (MDPI)出版的国际性学术期刊,创刊于2013年,以4 issues/year形式稳定发行,2026年总发文量约3073篇。该刊采用OA开放访问,学科归属为Biochemistry, Genetics and Molecular Biology - General Biochemistry,Genetics and Molecular Biology。该刊是医学、生化与分子生物学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.5,2025年期刊CiteScore为7.8,2025年期刊自引率约4.4%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Biomedicines长期聚焦医学、生化与分子生物学及相关产业的技术应用前沿,平均审稿周期8 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、生化与分子生物学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAItaly、GERMANY (FED REP GER)、South Korea、Japan、England、Russia等为核心发文国家与地区;RUSSIAN ACADEMY OF SCIENCESINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、RUSSIAN ACADEMY OF MEDICAL SCIENCES、UNIVERSITY OF MILAN、KYUNG HEE UNIVERSITY、CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN RED、UNIVERSITY OF CALIFORNIA SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 PHARMACOLOGY & PHARMACY 药学
3区 3区 3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 PHARMACOLOGY & PHARMACY 药学
3区 3区 3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
工程技术
3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 PHARMACOLOGY & PHARMACY 药学
3区 3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q2 103 / 328

68.8

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 59 / 191

69.4

学科:PHARMACOLOGY & PHARMACY SCIE Q2 90 / 356

74.9

学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q2 120 / 328

63.57

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 73 / 191

62.04

学科:PHARMACOLOGY & PHARMACY SCIE Q2 127 / 356

64.47

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q2 104 / 313

66.9

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 64 / 189

66.4

学科:PHARMACOLOGY & PHARMACY SCIE Q1 85 / 354

76.1

学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q2 91 / 313

71.09

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 59 / 189

69.05

学科:PHARMACOLOGY & PHARMACY SCIE Q2 105 / 354

70.48


中国学者近期发文

1
Neural Network-Based Prediction of Residual Paravalvular Leak in Bicuspid Aortic Valve TAVI Using CT-Derived Anatomical Feature

Author:Yao, Yijun; Jiang, Weili; Yang, Xinyue; Wang, Jianyong; Tang, Ruisi; Feng, Yuan; Li, Yiming; Chen, Mao

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040946

2
DYRK1B Inhibition by AZ191 Sensitizes High-Grade Serous Ovarian Cancer to Niraparib Through Promoting Apoptosis and Ferroptosi

Author:Gao, Yu; Cao, Yuanyuan; Liu, Junyao; Tong, Fang; Liu, Xianlin; Wang, Jiahui; Liu, Peixuan; Xu, Yanting; Feng, Lu; Zhang, Pengxin; Gao, Jingchun; Liu, Jiwei

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040939

3
Research Progress on Elesclomol-Induced Cuproptosis for Antitumor Effect

Author:Peng, Lingzhi; Sun, Na; Ren, Biqiong

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040910

4
Cellular Senescence in Keloid Pathology: Mechanisms, Biomarkers, and Potential Therapeutic Target

Author:Luo, Yujiang; Deng, Yaxiong; Yuan, Li; Fu, Siqi

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040912

5
Comparison and Characteristics of MASLD Mouse Model

Author:Wei, Li; Gao, Chunchen; Qin, Hongyan

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040895

6
From Pyroptosis Heterogeneity to an Interpretable Prognostic Signature for Risk Stratification and Therapy Insights in Pancreatic Adenocarcinom

Author:Zou, Xiangsen; Song, Peng; Song, Shicong; Zhang, Guowei; Xiao, Wang; Yang, Tingkang; Zhou, Lin; Lin, Yixiong

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040892

7
Andrographolide Suppresses Influenza A Virus-Induced Pyroptosis via PI3K/AKT-Mediated Caspase-3/GSDME Inactivatio

Author:Yang, Wen; He, Qi; Sun, Zhen; Zhang, Xiaochang; Li, Qingyu; Zhou, Changdong; Cui, Yuke; Wei, Zhenqiao; Shi, Jingqi; Wang, Chenhui; Jiao, Yuanyuan; Guo, Liang; Xing, Yaling; Wang, Shengqi

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040887

8
Immune Microenvironment and Genetic Signatures of End-Stage Renal Disease and Their Association with Sepsis: Insights from Public Transcriptomic Data and a Multicenter Clinical Cohor

Author:Wang, Sheng-Huei; Yang, Kuang-Yao; Sheu, Chau-Chyun; Wu, Biing-Ru; Chan, Ming-Cheng; Feng, Jia-Yih; Chen, Chia-Min; Shen, Yi-Cheng; Huang, Wei-Hsuan; Peng, Chung-Kan; Huang, Shih-Ming

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040885

9
Engineering Bone-Mimetic Microspheres to Recapitulate the Tumor Microenvironment for In Vitro Osteosarcoma Modelin

Author:Zheng, Fangqiao; Lan, Zhengyi; Chen, Hangrong; Ma, Ming

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040868

10
Prophylactic Nebulized hUC-MSC-EVs Attenuate Hypobaric Hypoxia-Induced Lung Injury via Alveolar-Capillary Barrier Stabilization and TEK/Tie2 Preservatio

Author:Wu, Peixin; Yin, Yue; Liu, Jinxia; Mo, Zhenfei; Ren, Jiabo; Ma, Xiuqing; Liang, Zhixin; Wang, Miaoyu; Li, Chunsun; Chen, Liangan

Journal: BIOMEDICINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/biomedicines14040874


在线咨询

Biomedicines

国际简称:BIOMEDICINES参考译名:生物医药

年发文量:3073 CiteScore:7.8 是否预警:否 Gold OA文章占比:99.97% 研究类文章占比:67.52%

杂志社联系方式:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052

Biomedicines